1. Nishimura T, Tsuchiyama M, Sakonjo H, Nakanishi J, Nakano D, lkeda H, et al. General pharmacological studies on risperidone. The Clin Rep. 1993;27(9):3665–88.
2. Committee on Drug Safety of the Pharmaceutical Affairs and Food Sanitation. [Revision of Precautions for adrenaline preparations] Adrenaline seizai no shiyojo no chui no kaitei ni tsuite. https://www.mhlw.go.jp/file/05-Shingikai-11121000-Iyakushokuhinkyoku-Soumuka/0000197888.pdf. Accessed Jan 31st, 2023.
3. Hanazawa T, Kamijo Y. Antipsychotic drugs and adrenaline. Jpn Med J. 2018;4916:46–51.
4. Ebisawa M. [Contraindications for co-administration of alpha-blocking antipsychotics and adrenaline] Alfa-shadan sayo wo yuusuru kou-seishinbyoyaku to adrenaline no heiyoukinki. J Tokyo Pediatr Asso. 2017;36(2):79–82.
5. Page CB, Calver LA, Isbister GK. Risperidone overdose causes extrapyramidal effects but not cardiac toxicity. J Clin Psychopharmacol. 2010;30(4):387–90.